Starpharma Holdings Limited (ASX:SPL) Directors Insider Transactions



The Directors and Chief Executives of Starpharma Holdings Limited (ASX:SPL) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Starpharma Holdings Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Starpharma Holdings Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Starpharma Holdings Limited Directors/Insider Transactions Activity

List of Insider trades activity from Starpharma Holdings Limited (SPL).

Date Director Director's Title Shares Value Note
11 Aug 2026 Thomas (Robert Bain) Independent Non-Executive Director 350,001 138,425 Other at price 0.40 per share.
11 Aug 2026 Basser (Russell) Independent Non-Executive Director 36,191 14,313 Other at price 0.40 per share.
11 Aug 2026 Cheng (Lynda) Independent Non-Executive Director 22,741 8,994 Other at price 0.40 per share.
11 Aug 2026 Davies (Jeff) Independent Non-Executive Director 117,291 46,388 Other at price 0.40 per share.
11 Aug 2026 Maley (Cheryl) Chief Executive Officer 16,667 6,591 Other at price 0.40 per share.
11 Aug 2026 Maley (Cheryl) Chief Executive Officer 0 - Other at price 0.40 per share.
16 Oct 2025 Thomas (Robert Bain) Independent Non-Executive Chairman 450,000 81,315 Purchase at price 0.18 per share.
23 Oct 2024 Thomas (Robert Bain) Non Executive Chairman 500,000 30,650 Purchase at price 0.06 per share.
13 Sep 2024 Basser (Russell) Independent Non-Executive Director 200,000 12,460 Purchase at price 0.06 per share.